semaglutide shortage ending Hims: Why The May End Imminently Judge Upholds FDA Deadline Ending

This element of unpredictability reinforces accountability and deters drug use among service members

According to FDA prescribing information, headache incidence differs by product and indication

CagriSema may price slightly higher as "evolution of Wegovy" from Novo Nordisk's established franchise

The findings are based on the STEP UP clinical weight management trial, the landmark SELECT clinical cardiovascular trial and one large-scale real-world evidence study, all presented at the European Congress on Obesity (ECO) 2026 in Istanbul, Trkiye

This is an important finding that helps enhance our treatment options. Our findings show that HTG is not a reason to withhold this class of medication from appropriate patients, if they would benefit otherwise